16:09 EDT Longeveron (LGVN) files $70M mixed securities shelf
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGVN:
- Longeveron’s Promising Alzheimer’s Program: Buy Rating Backed by FDA Alignment and Strategic Advancements
- Longeveron’s Promising Alzheimer’s Treatment and Favorable Regulatory Developments Drive Buy Rating
- Longeveron announces outcome of Type B meeting with FDA on Lomecel-B
- Longeveron announces publication of results of Phase 2a trial of Lomecel-B
- Biotech Alert: Searches spiking for these stocks today